Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 14, 2026Oct 15 8:44 PMSoleil BoughtonChief Legal Officer
Sale
3,461$29.06$100.6K297,348(D)

View →

Oct 14, 2026Oct 14 1:44 PMBoughton Soleil
Proposed Sale
3,461$29.06$100.6K—

View →

Oct 1, 2026Oct 2 8:32 PMOluyemi OkupeChief Financial Officer
Sale
2,000$29.70$59.4K234,527(D)

View →

Sep 30, 2026Oct 2 8:31 PMSoleil BoughtonChief Legal Officer
Sale
3,461$29.17$101.0K300,809(D)

View →

Oct 1, 2026Oct 1 4:05 PMOkupe Oluyemi
Proposed Sale
2,000$29.70$59.4K—

View →

Sep 30, 2026Sep 30 2:31 PMBoughton Soleil
Proposed Sale
3,461$29.17$101.0K—

View →

Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Sale
29,277$29.95$876.8K236,527(D)

View →

Sep 22, 2026Sep 22 4:12 PMOkupe Oluyemi
Proposed Sale
29,277$29.95$876.8K—

View →

Sep 17, 2026Sep 18 8:17 PMOluyemi OkupeChief Financial Officer
Sale
12,313$28.82$354.9K251,804(D)

View →

Sep 16, 2026Sep 17 8:17 PMSoleil BoughtonChief Legal Officer
Sale
6,236$27.86$173.7K304,270(D)

View →

Sep 15, 2026Sep 17 8:17 PMMichael ChiChief Operating Officer
Sale
14,027$28.39$398.2K456,660(D)

View →

Sep 15, 2026Sep 17 8:17 PMMohamed ElshenawyCTO
Sale
7,954$28.39$225.8K185,556(D)

View →

Sep 17, 2026Sep 17 7:55 PMOkupe Oluyemi
Proposed Sale
12,313$28.82$354.9K—

View →

Sep 16, 2026Sep 16 2:05 PMBoughton Soleil
Proposed Sale
6,236$27.86$173.7K—

View →

Sep 15, 2026Sep 15 2:22 PMElshenawy Mohamed
Proposed Sale
7,954$28.39$225.8K—

View →

Sep 15, 2026Sep 15 2:14 PMChi Michael
Proposed Sale
14,027$28.39$398.2K—

View →

Sep 2, 2026Sep 3 8:31 PMSoleil BoughtonChief Legal Officer
Sale
3,458$28.33$98.0K310,506(D)

View →

Sep 2, 2026Sep 2 4:24 PMBoughton Soleil
Proposed Sale
3,458$28.33$98.0K—

View →

Aug 18, 2026Aug 20 8:31 PMDeborah M. AutorDirector, Chief Policy Officer
Sale
16,773$27.85$467.1K48,961(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Sale
4,938$29.99$148.1K264,117(D)

View →

Page 1 of 11

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Option Exercise
14,000$5.0166,872(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,938$5.0180,872(D)

View →

Aug 14, 2026Aug 18 9:04 PMSoleil BoughtonChief Legal Officer
Option Exercise
42,261—164,598(D)

View →

Aug 14, 2026Aug 18 9:04 PMKare SchultzDirector
Option Exercise
6,623—6,624(D)

View →

Aug 14, 2026Aug 18 9:04 PMPatrick Harrison CarrollChief Medical Officer
Option Exercise
26,187—131,678(D)

View →

Aug 14, 2026Aug 18 9:04 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
154,993—362,114(D)

View →

Aug 14, 2026Aug 18 9:04 PMMichael ChiChief Operating Officer
Option Exercise
86,265—329,194(D)

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,388$5.0185,810(D)

View →

Aug 14, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
71,616—263,356(D)

View →

Aug 14, 2026Aug 18 9:04 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,920—427,953(D)

View →

Aug 14, 2026Aug 18 9:03 PMDavid B WellsDirector
Option Exercise
778—0(D)

View →

Aug 14, 2026Aug 18 9:03 PMMohamed ElshenawyCTO
Option Exercise
188,285—1,100,000(D)

View →

Aug 14, 2026Aug 18 9:03 PMIrene BecklundPAO
Option Exercise
13,685—54,317(D)

View →

Aug 14, 2026Aug 18 9:03 PMChristopher D PayneDirector
Option Exercise
545—0(D)

View →

Aug 12, 2026Aug 14 8:16 PMMohamed ElshenawyCTO
Grant/Award
1,200,000—1,200,000(D)

View →

Aug 12, 2026Aug 14 8:16 PMKare SchultzDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:16 PMChristopher D PayneDirector
Grant/Award
8,768—545(D)

View →

Aug 12, 2026Aug 14 8:15 PMGarcia Andrea G PerezDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMAnja ManuelDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMDelos M. CosgroveDirector
Grant/Award
8,223—8,223(D)

View →

Page 1 of 4

Next →